Patents by Inventor Holger Kanzler

Holger Kanzler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10548975
    Abstract: The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an immune response, and to methods for preparation of the branched chimeric compounds.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: February 4, 2020
    Assignee: DYNAVAX TECHNOLOGIES CORPORATION
    Inventors: Gary S. Ott, Robert J. Milley, Robert L. Coffman, Radwan Kiwan, Holger Kanzler
  • Publication number: 20190240323
    Abstract: The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an immune response, and to methods for preparation of the branched chimeric compounds.
    Type: Application
    Filed: April 20, 2018
    Publication date: August 8, 2019
    Inventors: Gary S. OTT, Robert J. MILLEY, Robert L. COFFMAN, Radwan KIWAN, Holger KANZLER
  • Patent number: 10350290
    Abstract: The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an immune response, and to methods for preparation of the branched chimeric compounds.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: July 16, 2019
    Assignee: DYNAVAX TECHNOLOGIES CORPORATION
    Inventors: Gary S. Ott, Robert J. Milley, Robert L. Coffman, Radwan Kiwan, Holger Kanzler
  • Publication number: 20180360954
    Abstract: The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an immune response, and to methods for preparation of the branched chimeric compounds.
    Type: Application
    Filed: April 20, 2018
    Publication date: December 20, 2018
    Inventors: Gary S. OTT, Robert J. MILLEY, Robert L. COFFMAN, Radwan KIWAN, Holger KANZLER
  • Patent number: 9950064
    Abstract: The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an immune response, and to methods for preparation of the branched chimeric compounds.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: April 24, 2018
    Assignee: Dynavax Technologies Corporation
    Inventors: Gary S. Ott, Robert J. Milley, Robert L. Coffman, Radwan R Kiwan, Holger Kanzler
  • Publication number: 20160213774
    Abstract: The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an immune response, and to methods for preparation of the branched chimeric compounds.
    Type: Application
    Filed: January 22, 2016
    Publication date: July 28, 2016
    Inventors: Gary S. Ott, Robert J. Milley, Robert L. Coffman, Radwan Kiwan, Holger Kanzler